Detalhe da pesquisa
1.
Safety, tolerability, and immunogenicity of the chimpanzee adenovirus type 3-vectored Marburg virus (cAd3-Marburg) vaccine in healthy adults in the USA: a first-in-human, phase 1, open-label, dose-escalation trial.
Lancet
; 401(10373): 294-302, 2023 01 28.
Artigo
Inglês
| MEDLINE | ID: mdl-36709074
2.
Safety, tolerability, pharmacokinetics, and immunogenicity of the therapeutic monoclonal antibody mAb114 targeting Ebola virus glycoprotein (VRC 608): an open-label phase 1 study.
Lancet
; 393(10174): 889-898, 2019 03 02.
Artigo
Inglês
| MEDLINE | ID: mdl-30686586
3.
Safety, tolerability, and immunogenicity of two Zika virus DNA vaccine candidates in healthy adults: randomised, open-label, phase 1 clinical trials.
Lancet
; 391(10120): 552-562, 2018 02 10.
Artigo
Inglês
| MEDLINE | ID: mdl-29217376
4.
Enhanced inflammation in New Zealand white rabbits when MERS-CoV reinfection occurs in the absence of neutralizing antibody.
PLoS Pathog
; 13(8): e1006565, 2017 Aug.
Artigo
Inglês
| MEDLINE | ID: mdl-28817732
5.
Safety and pharmacokinetics of the Fc-modified HIV-1 human monoclonal antibody VRC01LS: A Phase 1 open-label clinical trial in healthy adults.
PLoS Med
; 15(1): e1002493, 2018 01.
Artigo
Inglês
| MEDLINE | ID: mdl-29364886
6.
Prophylaxis With a Middle East Respiratory Syndrome Coronavirus (MERS-CoV)-Specific Human Monoclonal Antibody Protects Rabbits From MERS-CoV Infection.
J Infect Dis
; 213(10): 1557-61, 2016 May 15.
Artigo
Inglês
| MEDLINE | ID: mdl-26941283
7.
Seasonal trivalent inactivated influenza vaccine does not protect against newly emerging variants of influenza A (H3N2v) virus in ferrets.
J Virol
; 87(2): 1261-3, 2013 Jan.
Artigo
Inglês
| MEDLINE | ID: mdl-23115290
8.
Impact of prior seasonal H3N2 influenza vaccination or infection on protection and transmission of emerging variants of influenza A(H3N2)v virus in ferrets.
J Virol
; 87(24): 13480-9, 2013 Dec.
Artigo
Inglês
| MEDLINE | ID: mdl-24089569
9.
N-linked glycosylation of the hemagglutinin protein influences virulence and antigenicity of the 1918 pandemic and seasonal H1N1 influenza A viruses.
J Virol
; 87(15): 8756-66, 2013 Aug.
Artigo
Inglês
| MEDLINE | ID: mdl-23740978
10.
Immune memory shapes human polyclonal antibody responses to H2N2 vaccination.
Cell Rep
; 43(5): 114171, 2024 May 07.
Artigo
Inglês
| MEDLINE | ID: mdl-38717904
11.
Heterologous cAd3-Ebola and MVA-EbolaZ vaccines are safe and immunogenic in US and Uganda phase 1/1b trials.
NPJ Vaccines
; 9(1): 67, 2024 Mar 29.
Artigo
Inglês
| MEDLINE | ID: mdl-38553525
12.
Human pulmonary microvascular endothelial cells support productive replication of highly pathogenic avian influenza viruses: possible involvement in the pathogenesis of human H5N1 virus infection.
J Virol
; 86(2): 667-78, 2012 Jan.
Artigo
Inglês
| MEDLINE | ID: mdl-22072765
13.
Seasonal trivalent inactivated influenza vaccine protects against 1918 Spanish influenza virus infection in ferrets.
J Virol
; 86(13): 7118-25, 2012 Jul.
Artigo
Inglês
| MEDLINE | ID: mdl-22553323
14.
Immune memory shapes human polyclonal antibody responses to H2N2 vaccination.
bioRxiv
; 2023 Aug 24.
Artigo
Inglês
| MEDLINE | ID: mdl-37781590
15.
An influenza H1 hemagglutinin stem-only immunogen elicits a broadly cross-reactive B cell response in humans.
Sci Transl Med
; 15(692): eade4976, 2023 04 19.
Artigo
Inglês
| MEDLINE | ID: mdl-37075126
16.
An influenza hemagglutinin stem nanoparticle vaccine induces cross-group 1 neutralizing antibodies in healthy adults.
Sci Transl Med
; 15(692): eade4790, 2023 04 19.
Artigo
Inglês
| MEDLINE | ID: mdl-37075129
17.
Safety, tolerability, and immunogenicity of the Ebola Sudan chimpanzee adenovirus vector vaccine (cAd3-EBO S) in healthy Ugandan adults: a phase 1, open-label, dose-escalation clinical trial.
Lancet Infect Dis
; 23(12): 1408-1417, 2023 Dec.
Artigo
Inglês
| MEDLINE | ID: mdl-37544326
18.
A single residue in influenza virus H2 hemagglutinin enhances the breadth of the B cell response elicited by H2 vaccination.
Nat Med
; 28(2): 373-382, 2022 02.
Artigo
Inglês
| MEDLINE | ID: mdl-35115707
19.
Safety and immunogenicity of a ferritin nanoparticle H2 influenza vaccine in healthy adults: a phase 1 trial.
Nat Med
; 28(2): 383-391, 2022 02.
Artigo
Inglês
| MEDLINE | ID: mdl-35115706
20.
Safety and immunogenicity of an HIV-1 prefusion-stabilized envelope trimer (Trimer 4571) vaccine in healthy adults: A first-in-human open-label, randomized, dose-escalation, phase 1 clinical trial.
EClinicalMedicine
; 48: 101477, 2022 Jun.
Artigo
Inglês
| MEDLINE | ID: mdl-35783486